Dr. Anawin Sanguankeo, MD

Dr. Sanguankeo practices at PeaceHealth St. John Medical Center in Longview, Washington, part of PeaceHealth.

Dr. Sanguankeo's NPI, 1043637580, was assigned on March 22, 2014. Dr. Sanguankeo holds Washington license MD61239740.

Dr. Sanguankeo's primary practice is PeaceHealth St. John Medical Center, at 1615 Delaware Street, Longview, WA 98632 in Cowlitz County. The practice phone is (360) 414-2000.

Dr. Sanguankeo's primary practice is PeaceHealth St. John Medical Center in Longview, Washington, part of PeaceHealth. Dr. Sanguankeo is also affiliated with PeaceHealth Southwest Medical Center. The medical group on file is PeaceHealth St. John Medical Center. Dmand AI also links Dr. Sanguankeo to 3 more hospitals and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sanguankeo practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Sanguankeo's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Sanguankeo's licenses on file in 2 states: Washington and Illinois.

CMS data shows 950 Medicare services from Dr. Sanguankeo across 10 procedure codes in 2024, for 190 Medicare patients. Medicare paid $60,612 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 190 Medicare patients who saw Dr. Sanguankeo in 2024. The largest group is 75 to 84, with 74 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 21% are also on Medicaid. Their average risk score is 3.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sanguankeo's median patient age at 74, with 53% women.

In 2024, Dr. Sanguankeo wrote 1,248 Medicare Part D claims for 316 patients. 83% of them were for generic drugs. CMS names the drug for 1,055 of them, across 29 drugs with 11 or more claims each, at $198,771 in total drug cost. In 2023, CMS named 320 claims across 15 drugs.

Dr. Sanguankeo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sanguankeo as offering telehealth.

Dmand AI links 97 papers to Dr. Sanguankeo, published from 2013 to 2023. 2015 was the busiest year, with 24. The most frequent topics are Non-alcoholic Fatty Liver Disease, Observational Studies as Topic and Bariatric Surgery. Dr. Sanguankeo has published most often in Surg Obes Relat Dis. Dr. Sanguankeo's most frequent co-authors are Sikarin Upala, MD, Veeravich Jaruvongvanich, MD and Karn Wijarnpreecha, MD, MPH.

CMS Open Payments shows 267 general payments to Dr. Sanguankeo from 29 drug and device companies from 2019 to 2022. Food and beverage make up the largest share, 76% of the total. Fresenius USA Marketing, Inc. paid the most, $1,391.